Physician profile
Aaron J Albers
NPI 1295044212
$7,551.50
in general payments reported to CMS, 2019-2025
17 companies · $2,161 in 2025
The $2,161 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2022: $1,219 · 2023: $1,351 · 2024: $2,537 · 2025: $2,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,596 · Food and Beverage: $2,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,596.19 |
| Food and Beverage | $2,452.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,042.05 | 2024-2025 | Gryphon Orthocord, Motoband, Truespan Orthocord |
| Stryker Corporation | $1,483.77 | 2022-2024 | 1788, Infinity, Dart-Fire |
| Sioux Surgical INC | $1,069.22 | 2023-2025 | |
| Depuy Synthes Sales INC. | $711.91 | 2019-2025 | N/A, Na, Dynacord |
| Paragon 28, INC. | $390.76 | 2025 | Apex 3d |
| Organogenesis INC. | $303.88 | 2019-2025 | Cygnus Dual, Puraply Wound Matrix, Puraply |
| Smith+Nephew, INC. | $201.65 | 2022-2025 | Grafix Pl, Grafix, Grafix Xc |
| Merck Sharp & Dohme LLC | $76.05 | 2019 | |
| Melinta Therapeutics, LLC | $74.97 | 2019-2024 | Rezzayo |
| Davol INC. | $41.71 | 2019 | |
| Integra Lifesciences Corporation | $35.62 | 2019 | |
| Convatec INC. | $31.67 | 2025 | |
| Arthrex, INC. | $24.00 | 2023 | |
| Polynovo North America LLC | $19.76 | 2025 | Novosorb Btm |
| Innovation Technologies INC | $15.93 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $15.46 | 2025 | V.A.C. Veraflo, Prevena, 3m Cavilon |
| Kerecis Limited | $13.09 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Albers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.